Treating multi drug resistant TB and HIV/AIDS in Manipur, India

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines.

During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in developed countries, remarkable progress was being made in the field of health. Two decades on, medicines in developing countries are still either too expensive, aren't suitable to be used in many of the contexts in which we work (for example, in hot, humid conditions or where there's a lack of electricity), or simply don't exist for the diseases we need to treat.

In 1999, we launched the Campaign for Access to Essential Medicines, now known as the Access Campaign. Its mission focuses on three areas: overcoming barriers to access to essential medicines, stimulating research and development for neglected diseases, and promoting health exceptions to global trade agreements. In 2003, MSF joined several research institutes, including the Institut Pasteur, to create the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organisation engaged in research and development of new treatments for neglected diseases.

Website

MSF Access Campaign

msfaccess.org
 
MSF HIV Testing Clinic's in Conakry
Access to medicines

HIV and TB treatment at risk as countries gradually lose Global Fund support

Press Release 13 Nov 2018
 
TB programs in Gulf Province and Port Moresby
Tuberculosis

High prices restrict access to best drug-resistant tuberculosis treatment

Press Release 23 Oct 2018
Sibongile Xesha - MSF Treatment For TB in South Africa
Tuberculosis

DR-TB Drugs Under the Microscope, 5th Edition (Abridged)

msfaccess.org 22 Oct 2018
 
Snakebite Amputation
Snakebite

Time to strike back at snakebite and end the antivenom access crisis

Report 19 Sep 2018
TB treatments yield promising results in the Chechen Republic
Tuberculosis

Open Letter to J&J: Calling for affordable access to critical TB drug bedaquiline

msfaccess.org 17 Sep 2018
 
Out of Darkness- fighting Hepatitis C
Hepatitis C

MSF calls for end to Gilead’s hepatitis C drug monopoly

Press Release 11 Sep 2018
 
Insein clinic, for treatment for HIV, TB, and Hepatitis C in Yangon. By Alessandro Penso, Feb 2018.
Tuberculosis

MSF applauds World Health Organization’s recommendation of improved tuberculosis treatment options

Press Release 17 Aug 2018
 
Out of Darkness- fighting Hepatitis C
Photo Story

Out of Darkness: Fighting Hepatitis C in Ukraine

27 Jul 2018
Photo Story
 
Tanya and Florence - Living With HIV
HIV/AIDS

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

Press Release 23 Jul 2018